There is now strong evidence that the chorioretinal ornithine disappearance from the medium that is signifidegeneration associated with ornithine-␦-aminotransferase cantly higher than the rate of disappearance from the (OAT) deficiency is a consequence of hyperornithinemia. medium bathing normal keratinocytes. In addition, OAT Therefore development of a metabolic system for clearing activity determined in soluble protein prepared from sonornithine from the circulation is being pursued as a potenicates suggests that the capacity to maintain plasma ornitial treatment. The skin is considered an attractive location thine within the normal range is contained within an for such a metabolic system because autologous cells can accomplishable graft of keratinocytes overexpressing OAT. be safely and easily utilized. This study was undertaken to However, the actual rate of ornithine disappearance from determine the ornithine metabolizing capacity of epidermal the media was significantly less than predicted from keratinocytes expressing normal and superphysiologic enzyme activity assays. Following ornithine metabolite proamounts of OAT. The data show that overexpression of duction by intact cells suggests that ornithine metabolism OAT in keratinocytes cultured from a gyrate atrophy patient is limited primarily by clearance of downstream metabrestores ornithine metabolism and results in a rate of olites, as opposed to substrate delivery.
Introduction
amenable to gene replacement therapy since successful In some inherited metabolic disorders pathology results treatment requires only that the concentration of the toxic from accumulation of a metabolite to toxic levels in the metabolite be reduced. Because the gene need not be body. Examples of such diseases are familial hyperreplaced in the affected organ or organs, the choice of cholesterolemia, phenylketonuria, adenosine deaminase target tissue for gene replacement can be based on deficiency and ornithine transcarbamoylase deficiency.
characteristics such as ease of access and manipulation, There is now evidence that gyrate atrophy (GA) of the and the metabolic attributes of the chosen cell. It has been choroid and retina also belongs on this list. Clinical trials suggested that several properties of the skin make it a of dietary arginine restriction in GA patients suggest that suitable organ for gene therapy. [4] [5] [6] Among these are the the chorioretinal degeneration associated with the relative ease of obtaining and culturing cells of the skin; absence of a functional ornithine-␦-aminotransferase the existence of established protocols for genetically enzyme (OAT; EC 2.6.1.13) results from accumulation of modifying skin cells and returning them to patients; the ornithine in the body. Maintenance of fasting plasma ease of access to genetically modified cells in vivo; and a ornithine at or below 200 m (normal range: 40-140 m) blood supply that can exceed metabolic demand by 10-appears markedly to slow progression of the chorioretifold. nal degeneration in GA patients. [1] [2] [3] Unfortunately, longAs a first step in the development of the skin as a target term maintenance of plasma ornithine in the effective organ for OAT gene replacement therapy, ornithine range has been achieved in fewer than one-third of the metabolism was investigated in normal and GA patient patients placed on arginine restriction. Therefore, somatic keratinocytes overexpressing OAT. The goals of this gene replacement therapy is being investigated as an study were: (1) to determine if ornithine metabolism can alternative or adjunct approach to the treatment of this be restored in keratinocytes cultured from GA patients; disease.
(2) to determine if an OAT activity expected to be capable It might be expected that diseases resulting from the of clearing the daily ornithine load can be achieved in keratinocytes; and (3) to quantify ornithine metabolism by intact keratinocytes. Results obtained using an adeno-extracts from transduced cells suggests that the enzyme disappearance. The values shown in Table 1 , for initial rate of disappearance at the physiologically relevant orniis expressed in sufficient quantity to allow for clearance of the daily ornithine load by an accomplishable graft.
thine concentration of 0.1 mm were calculated as described in Materials and methods. This potential is apparently not realized in the intact cell however, as the rate of ornithine disappearance from the Ornithine disappearance from the medium bathing intact medium bathing intact cells was considerably lower than keratinocytes that predicted from OAT enzyme activity. Possible causes
The ability of transduced and untransduced keraof this disconnection between enzyme activity and ornitinocytes to clear ornithine from the culture medium was thine disappearance, and strategies for further engineermeasured in order to determine if replacement of OAT ing keratinocytes to improve the rate of ornithine metabin keratinocytes from GA patients restores ornithine olism are discussed.
catabolism, and to determine if OAT overexpression enhances the rate of ornithine disappearance. First, the
Results
possible presence of extracellular ornithinase activity was ruled out in preliminary experiments by determining the OAT expression in normal and GA patient keratinocytes stability of ornithine in medium conditioned by transTransduction using an adenovirus vector has been demduced keratinocytes. In these experiments, a 4 h incuonstrated to be a useful method to obtain high-level probation in medium conditioned for 2 h by transduced tein expression in a variety of mammalian cells. 7, 8 Therekeratinocytes resulted in no diminution in the magnitude fore, for the purpose of in vitro analysis, an adenovirus of the ornithine peak (data not shown). There was also vector was used to transfer the OAT gene into kerano measurable ornithinase activity in untransduced GA tinocytes. OAT protein, detectable by Western blot patient keratinocytes (Figure 2 ), indicating that ornithine in normal keratinocytes, was undetectable in cultured metabolism by non-OAT pathways could be ignored in GA patient keratinocytes ( Figure 1 ). Transduction of these experiments. both normal and GA patient keratinocytes with
The rate of ornithine disappearance from the medium Ad/CMV.OAT resulted in overexpression of OAT with bathing normal keratinocytes was low ( Figure 2 ). The a multiplicity of infection (MOI) of 100 plaque forming ornithine concentration in medium incubated for 4 h with units (p.f.u.) per cell being maximally effective. No gross normal keratinocytes was only slightly lower than in morphological changes were apparent in keratinocytes medium incubated with untransduced GA patient keratransduced at an MOI of 1000 p.f.u. per cell, suggesting tinocytes (0.089 ± 0.001 mm (n = 3) versus 0.096 ± that even this relatively high concentration of virus is 0.001 mm (n = 3), respectively). In contrast, both normal well tolerated. Therefore, transductions for subsequent and GA patient keratinocytes overexpressing OAT experiments were performed at 1000 p.f.u. per cell in cleared greater than 40% of the ornithine from the order to minimize differences in transduction efficiency medium in a 4 h period, indicating that OAT gene and protein expression from one experiment to the next.
replacement does restore ornithine metabolism in GA OAT activity in soluble protein extracts from transduced patient cells and that overexpression of OAT in kera-GA patient keratinocytes was found to plateau within 2 tinocytes results in a greater than normal rate of ornithine days of transduction at approximately 25 times the catabolism. The actual rate of ornithine disappearance activity measured in normal keratinocytes ( Table 1) . The from the medium bathing both transduced and untransenzyme activity measured in transduced normal keraduced keratinocytes was, however, less than predicted tinocytes was approximately 16-fold higher than in from OAT enzyme activity in soluble protein prepuntransduced normal cells. For the purpose of compariarations. Hypothetical clearance curves generated based son with data obtained from intact cells (Figure 2 ), the on enzyme activity predict that 90% of the ornithine specific activities were converted to units of ornithine would be removed from the medium by 4.7 h for untransduced normal keratinocytes ( Figure 2 , solid line) and by 0.3 h for transduced normal keratinocytes ( Figure  2 , dashed line). Possible reasons for the difference in predicted and observed rates of ornithine disappearance from the medium are discussed below.
Rates of ornithine metabolism in transduced and untransduced keratinocytes Because ornithine disappearance from the medium bathing untransduced keratinocytes was difficult to measure, metabolite production was used for the purpose of comparing metabolism in transduced and untransduced keratinocytes. The complete OAT reaction cycle is composed of two half reactions:
Ornithine + pyridoxal-OAT→glutamate The initial product of ornithine metabolism by OAT, glutamate semialdehyde, is further metabolized to glutathe TCA cycle probably does not significantly affect the relative rate of ornithine metabolite production measured mate or undergoes spontaneous isomerization to form P5C. P5C can then be reduced to form proline in an in normal keratinocytes and keratinocytes overexpressing OAT. enzyme catalyzed reaction. In the experiments described, the OAT pathway was assumed to be at steady state. The
To control for possible differences in the rate of protein synthesis from one experiment to the next, the rate of flux through the pathway was estimated from the rate of 14 C incorporation into TCA precipitable material, and ornithine metabolite incorporation into cell protein was normalized to leucine incorporation. Leucine incorporfrom the rate of acid soluble ornithine metabolite accumulation in the culture medium.
ation was linear with respect to time ( Figure 5a ) and the rate of incorporation did not differ significantly in transTo ensure that ornithine metabolism was not limited by depletion of ␣-ketoglutarate, experiments were perforduced and untransduced normal keratinocytes (7.3 ± 0.3 nmol/h (n = 3) versus 6.0 ± 0.6 nmol/h (n = 4), med to investigate the effect of varying ␣-ketoglutarate concentration on the production of ornithine metabolites respectively). Leucine incorporation by GA patient keratinocytes (2.9 ± 0.4 nmol/h (n = 3) in untransduced cells by cells overexpressing OAT. At an l-ornithine concentration of 0.1 mm, varying ␣-ketoglutarate concentration and 2.7 ± 0.6 nmol/h (n = 3) in transduced cells) was, however, significantly lower than in normal keraover a 1000-fold range does not significantly change the rate of ornithine metabolite production by transduced tinocytes. The reason for this is unknown, although it does not appear to be a consequence of defective ornigyrate atrophy patient keratinocytes ( Figure 3a ). In contrast, there was a dose-dependent enhancement of ornithine metabolism since leucine incorporation was not different in transduced and untransduced GA patient kerathine metabolism by ␣-ketoglutarate when the ornithine concentration was increased to 5 mm ( Figure 3b ). This tinocytes. The difference in leucine incorporation into protein might, however, represent a difference in amino finding suggests that ␣-ketoglutarate added to the assay medium does cross the keratinocyte inner mitochondrial acid trafficking or metabolism that could affect ornithine metabolism. Because such differences might confuse membrane. Because ␣-ketoglutarate can inhibit the OAT reaction at concentrations above 3 mm 9 the interinterpretation of experiments designed to compare ornithine metabolism in cells expressing OAT at the normal mediate concentration of 1 mm was chosen for subsequent experiments.
endogenous level to metabolism in cells expressing OAT at a superphysiological level, comparative analysis of Experiments were also performed to determine production of radiolabeled CO 2 by transduced and untransornithine metabolism was limited to transduced and untransduced normal keratinocytes. Control experiments duced normal keratinocytes. Because the ornithine tracer used was labeled at the C1 position it was possible that were also performed on normal keratinocytes to determine if adenovirus transduction alone might affect the a significant amount of the metabolized ornithine could escape detection by entering the TCA cycle as ␣-rate of ornithine metabolism. In these experiments it was found that transduction (MOI = 1000 p.f.u. per cell) with ketoglutarate, in which case the 1-carbon is lost as CO 2 . In these experiments it was found that OAT was required an E1-deleted adenovirus that does not contain an insert in the expression cassette did not significantly alter the for significant accumulation of CO 2 from ornithine, as production by untransduced GA patient keratinocytes rate of OAT metabolite production. Accumulation of ornithine metabolites in the media over a 4 h period was was low (Figure 4) . Overexpression of OAT, however, did not result in a rate of CO 2 production that was greater measured at 1.2 ± 0.17 nmol for untransduced normal keratinocytes versus 1.6 ± 0.25 nmol for transduced than the rate measured in untransduced normal keratinocytes. Therefore, movement of ornithine carbon into normal keratinocytes (n = 3; P = 0.2). extrapolated to a point on the Y-axis that was greater than zero, suggesting a rapid early phase with slowing at later time-points. This is probably due, in part, to the The rate of ornithine metabolism by intact keradecrease in ornithine concentration in the medium. Howtinocytes was substrate dependent and overexpression of ever, accumulation of metabolites between 1 and 4 h, OAT resulted in a significant increase in the apparent over which time ornithine in the medium decreased 30%, V max (Figures 5b and 6b ) of metabolite production. At the was nearly linear. Therefore, the apparent slowing of physiologically relevant ornithine concentration of metabolite accumulation over the first hour might also 0.1 mm, the rate of ornithine incorporation into protein reflect a refilling of metabolite pools that were depleted was linear (Figure 5a ) and significantly higher in transin the preincubation period. The rapid early phase was duced cells (0.056 ± 0.021 nmol/h/nmol l (n = 3)) than in not evident in metabolite incorporation into protein. untransduced cells (0.015 ± 0.002 nmol/h/nmol l (n = 4)).
However, in these experiments a significant lag, as This was also the case for accumulation of ornithine metabolites make their way into protein, might mask the metabolites in the incubation medium (Figure 6a occurs, in large part, as a consequence of hyperornithinemia. [1] [2] [3] Therefore, development of a metabolic system for clearing ornithine from the circulation, an ornithine sink, is being pursued as a potential treatment for GA.
suggest that the level of OAT expression attained would be sufficient to maintain plasma ornithine in the normal As a first step towards developing a skin-based ornithine sink, this study was undertaken to establish the efficacy range (40-140 m). This assertion is based on a target elimination rate calculated from the daily ornithine load of OAT gene replacement in keratinocytes cultured from GA patients, and to acquire basic information concerning for an adult on moderate protein restriction, 1 and clinically acceptable limitations on graft size. Thus, in order ornithine metabolism by intact cells to be used in the development of an effective therapy. Because none of the for a 20 × 20 cm graft, containing an estimated 2 × 10 9 keratinocytes 13 to clear a daily ornithine load of 20 mmol, animal models of hyperornithinemia are suitable for testing keratinocyte grafts in vivo, in vitro assays were an elimination rate of 0.83 mm/h/2 × 10 6 cells would be required. Achieving this rate is made significantly more developed for the purpose of quantifying ornithine metabolism in intact cells.
difficult by the fact that it must be accomplished at a plasma ornithine concentration greater than 1 log unit Transduction using an adenovirus vector has been demonstrated to be a useful means of obtaining highbelow the K m of OAT for ornithine. None the less, estimating the initial rate of ornithine disappearance at level protein expression in a variety of human cells. Therefore an adenovirus was used to transfer the OAT 0.1 mm l-ornithine from enzyme activity data suggests that transduced GA patient keratinocytes have the potengene into keratinocytes. Although it is impossible to be certain just how much OAT enzyme activity will be tial to remove ornithine at twice the requisite rate. To accomplish this, however, 25-fold overexpression of OAT required for an effective ornithine sink, predicted rates of ornithine disappearance calculated from the enzyme is necessary.
Although there have been reports of OAT gene replaactivity measured in transduced keratinocytes (Table 1) pearance by keratinocytes can be significantly enhanced by overexpressing OAT. The actual rate of ornithine disappearance from the medium bathing both normal and transduced keratinocytes was, however, less than predicted from enzyme activity. This finding is not surprising given the complexity and interconnectedness of metabolic pathways. However, although flux through a metabolic pathway is generally not a linear function of the activity of any one enzyme in that pathway, 18,19 it might still be possible to produce large changes in flux by making changes at multiple points along the pathway. 20 Among the factors that could affect ornithine metabolism in the intact cell are transport of ornithine across the plasma membrane and inner mitochondrial membrane, cofactor concentration, and accumulation of reaction products. Data obtained with isolated mitochondria suggest that OAT activity in the liver is rate limited by transport across the inner mitochondrial membrane. 21 If this were the case in keratinocytes, overexpression of OAT would be expected to have little effect since the kinetics of ornithine metabolism would be defined by substrate transport regardless of the level of OAT enzyme. In contrast, OAT overexpression resulted in a significant increase in the apparent V max of ornithine metabolism by intact keratinocytes. This finding indicates that transport does not limit ornithine metabolism in keratinocytes expressing OAT at the normal endogenous level. However, it is conceivable that transport becomes limiting in cells overexpressing OAT. This could explain, in part, why 16-fold overexpression of OAT results in only sixfold enhancement of ornithine metabolism.
The OAT reaction involves the cofactor pyridoxal phosphate and the cosubstrate ␣-ketoglutarate. It is unlikely that ornithine metabolism by OAT is limited by availability of pyridoxal phosphate since it is not consumed in the reaction. ␣-Ketoglutarate, on the other hand, is consumed, and it is conceivable that the avail- through the OAT pathway and even reversal of the pathway is accomplished in vivo by coordinate regulation of OAT and enzymes downstream of OAT. 23 The rate of cement in a variety of cell types, 14,15-17 none thus far have investigated the impact of gene replacement on ornithine accumulation of ornithine metabolites in the medium bathing cells overexpressing OAT appears to slow in the metabolism by the intact cell. Therefore, the effectiveness of OAT replacement in GA patient cells is unclear. Moniearly part of the incubation and then become linear. This finding is consistent with a slowing of the OAT reaction toring ornithine concentration in the medium bathing keratinocytes reveals that overexpression of OAT does as downstream metabolite pools come to steady state. Thus, the most significant factor limiting the rate of orniresult in a significantly greater rate of ornithine disappearance from the medium in both normal and GA thine disappearance from medium bathing intact cells is probably downstream elimination of ornithine metapatient keratinocytes. This finding demonstrates that replacing OAT restores ornithine metabolism in gyrate bolites. It might therefore be beneficial to co-overexpress enzymes, such as P5C dehydrogenase or P5C reductase, atrophy patient cells and that the rate of ornithine disap-that would presumably reduce the size of the metabolite of 1 n and loaded on to Dowex AG 50W-X8 cation exchange resin (Bio-Rad, Hercules, CA, USA). The reacpool immediately downstream of OAT.
Keratinocytes were chosen as a target cell for develoption product (predominantly P5C under the conditions used), 28 was eluted from the resin with 1 n HCl and ment of an orthinine sink because of characteristics that make them particularly amenable to genetic manipucounted in a Hydrofluor (National Diagnostics, Atlanta, GA, USA) scintillation cocktail. lation. It is possible that other cell types might be better suited to development of an ornithine sink. For example, For the purpose of comparison with data obtained from intact cells, the enzyme activities were determined it is arguable that under normal circumstances the liver clears more ornithine than any other single organ. Howin soluble proteins prepared from cells transduced in parallel with cells used in the intact cell assay. In addition, ever, it is also arguable that the liver is not the best choice for OAT gene replacement. In normal liver expression of the enzyme activities were converted to rates of ornithine disappearance by presupposing a 1:1 relationship OAT is restricted to a thin band of hepatocytes surrounding the central vein 24,25 that do not express urea cycle between ornithine disappearance and P5C formation. The values for the rate of ornithine disappearance at 0.1 mm enzymes. 26 The zonation of ornithine metabolic pathways in the liver presumably prevents competition for subl-ornithine (v 2 ) were calculated from disappearance at 0.7 mm (v 1 ) by assuming simple Michaelis-Menten kinstrate and suggests that indiscriminate expression of OAT in hepatocytes might be ineffective as a result of etics 21, 29, 30 and using the equation: competition from the ornithine transcarbamoylase pathway. In reality, the development of any organ to act as reduced and loaded on to 8% acrylamide gels. Following An epidermal keratinocyte culture established from skin electrophoresis, the proteins were transferred to Immobisamples from a GA patient and normal human keralon-P (0.45 m PVDF; Millipore, Bedford, MA, USA) tinocytes (Clonetics, San Diego, CA, USA) were mainmembrane and OAT protein was detected using rabbit tained in complete keratinocyte medium (three parts Dulanti-human OAT antiserum. Antigen-antibody combecco's minimal essential medium, one part Ham's F12, plexes were detected with 125 I-protein A. 0.18 mm adenine, 0.5 g/ml hydrocortisone, 5 g/ml insulin, 0.1 nm cholera toxin, 10 ng/ml EGF, 100 IU/ml Measurement of ornithine metabolism in intact cells penicillin, 100 g/ml streptomycin and 10% fetal bovine Quantitative assays for ornithine disappearance and proserum) on a feeder layer of ␥-irradiated 3T3 cells as duction of ornithine metabolites by intact keratinocytes described. 27 For transduction, keratinocyte cultures were were developed based on protocols described by Gray exposed to the adenovirus construct Ad/CMV.OAT 14 in and co-workers. 31 Transduced and untransduced keracomplete keratinocyte medium that did not contain tinocytes in six-well cluster dishes were allowed to equiserum 1 day after coming to confluence. After a 90 min librate for 2 h at 37°C in Earl's balanced salt solution incubation, an equal volume of complete keratinocyte (EBSS; Gibco-BRL, Gaithersburg, MD, USA) containing medium containing 2 × serum was added to the culture 50 mm Hepes buffer, pH 7.0, and ␣-ketoglutarate at a and the incubation was continued until the cells were concentration of 1 mm unless otherwise indicated. After used in assays. All cells were used within 3 days of transthe preincubation, the media were replaced with assay duction (4-5 days after coming to confluence). medium consisting of EBSS containing 50 mm Hepes, pH 7.0, ␣-ketoglutarate, 0.3 Ci/ml l-[1-14 C]ornithine (Amersham, Arlington Heights, IL, USA), and l-ornithine Measurement of OAT enzyme activity and protein Enzyme activity and Western blot analysis of OAT at the concentration indicated for each experiment. In some experiments 0.1 Ci/ml l- [4, H]leucine expression in keratinocytes was performed as described.
14 Briefly, soluble proteins were prepared from (Amersham) and 2 mm l-leucine (Sigma) were included in the assay medium for the purpose of normalizing keratinocytes by sonicating cells in 100 m KPO 4 buffer, pH 8.0, containing 15 m pyridoxal phosphate (Sigma, St results to incorporation of leucine into cell protein. Cells were incubated in assay medium at 37°C in a 5% CO 2 , Louis, MO, USA), and pelleting the insoluble material. Protein concentration in the supernatant was determined humidified air incubator with constant shaking. The assay was terminated by removing the medium and using Coomassie Plus Protein Assay Reagent (Pierce, Rockford, IL, USA) and the manufacturer's protocol.
washing the cells with ice-cold Dulbecco's PBS (Biofluids, Rockville, MD, USA). In those assays in which incorporFor determination of enzyme activity, soluble protein was incubated for 30 min at 37°C in the presence of ation of amino acids into cell protein was not determined, 0.1 n NaOH was added immediately to the washed cells 0.1 Ci of l- [2,3- 3 H]ornithine (New England Nuclear, Boston, MA, USA), 700 m l-ornithine (Sigma), 16 m and cell protein was determined with Coomassie Plus Protein Assay Reagent according to the manufacturer's pyridoxal phosphate (Sigma), 700 m ␣-ketoglutarate (Sigma) and 100 m KPO 4 , pH 8.0. The reactions were directions. To determine incorporation of ornithine metabolites into cell protein, protein was precipitated in terminated by the addition of HCl to a final concentration P5C, proline and glutamate standards (data not shown), and present only in medium conditioned by cells expressing OAT (Figure 7 ) was presumed to represent ornithine metabolites generated via the OAT pathway (Figure 8) . Therefore, ornithine metabolite accumulation in the medium was determined by counting 14 C eluted in the first 8 ml of 1 n HCl. Counts in the 1 n HCl eluate from a sample of the assay medium that was removed and acidified immediately after being placed on to the cells were subtracted from counts in the same fraction of the other samples. A 14 C peak coeluting in 2 n HCl with an ornithine standard (data not shown) and diminished with increasing OAT activity (Figure 7 ) was presumed to represent orni- [Orn] t = ͩ 14 C t 14 C 0
the dish with ice-cold 5% TCA. After washing three times where 14 C t represents 14 C counts in the ornithine peak with ice-cold 5% TCA, the precipitated proteins were disfrom media sampled at time t, 14 C 0 represents 14 C counts solved in 1 ml 0.1 n NaOH, neutralized and mixed with in the ornithine peak from media sampled immediately 10 ml Hydrofluor scintillation cocktail. Leucine and orniafter being placed on to the cells, and Immediately after being removed from the culture tissue culture flasks were allowed to equilibrate for 2 h dish, the incubation media were acidified by adding HCl at 37°C in EBSS containing 50 mm Hepes, pH 7.0 and to a final concentration of 1 n. The acidified media were 1 mm ␣-ketoglutarate. After the preincubation, the media incubated on ice for at least 5 min and insoluble material were replaced with 2 ml assay medium consisting of was removed by centrifuging for 1 min at 12 000 g. The EBSS containing 50 mm Hepes, pH 7.0, 1 mm ␣-ketoglutasupernatants were then loaded on to Dowex AG 50W-X8 rate, 0.3 Ci/ml l-[1-14 C]ornithine and 1 mm l-ornithine. cation exchange resin to separate ornithine from orniThe mouth of the flask was then covered with a 1 cm 2 thine metabolites. A 14 C peak coeluting in 1 n HCl with piece of Whatman 3 MM filter paper (Whatman International, Maidstone, UK) that had been saturated with 1 m KOH (approximately 100 l), and sealed with Parafilm. Incubations were carried out at 37°C with constant shaking. At the time-points indicated in Figure 4 , the Whatman paper was removed and transferred to a scintillation vial containing 1 ml of 0.1 n HCl. Ten milliliters of Hydrofluor were added and 14 C trapped in the filter was determined by liquid scintillation counting. Cells in the flask were washed with ice-cold Dulbecco's PBS and lysed with 0.1 n NaOH. 14 C trapped by the filter was normalized to protein content of the cell lysate as described previously.
Data analysis
All data are presented as the mean ± s.e.m. of the indicated number of experiments. Statistical significance of differences between means was determined by unpaired comparison using a two-tailed Student's t test. Differences with P values р0.05 were considered significant. Values for apparent K m and V max were determined by 
